網羅的ゲノム解析を端緒に新規の分子病態の解明に至った重症アトピー性皮膚炎、喘息、食物アレルギー、好酸球性胃腸炎等を呈する疾患と標的治療薬開発の可能性

  • 柳 久美子
    成育医療研究センター・ゲノム医療研究部
  • 竹内 一朗
    成育医療研究センター・小児内科系専門診療部消化器科
  • 高田 修治
    成育医療研究センター・システム発生・再生医学研究部
  • 寺尾 美穂
    成育医療研究センター・システム発生・再生医学研究部
  • 野村 伊知郎
    成育医療研究センター・好酸球性消化管疾患研究室
  • 新井 勝大
    成育医療研究センター・小児内科系専門診療部消化器科
  • 松本 健治
    成育医療研究センター・免疫アレルギー感染研究部
  • 要 匡
    成育医療研究センター・ゲノム医療研究部
  • 森田 英明
    成育医療研究センター・免疫アレルギー感染研究部

書誌事項

タイトル別名
  • A novel mechanism for developing multiple allergic symptoms including severe atopic dermatitis, food allergy, asthma, and eosinophilic gastroenteritis, and a potential for development of molecular targeted drug

抄録

<p>Allergic diseases are recognised as "common diseases” caused by multiple factors including genetic predisposition and environmental factors. However, in some patients with allergic diseases, comprehensive genomic analyses such as whole-exome sequencing (WES) analysis have recently revealed a causative single gene, which might be a good target molecule for drug discovery. In our WES analysis, a diagnosis was made in 42% of patients with some allergic symptoms, suggesting that allergic diseases, which are “common diseases”, include monogenic diseases.</p><p>In this symposium, we will present a severe case with multiple allergic symptoms in which a novel causative gene, STAT6 was identified by WES analysis. The proband showed multiple allergic symptoms including severe atopic dermatitis, food allergy, asthma, and eosinophilic gastroenteritis. In vitro experiments demonstrated that the STAT6 variant acted in a constitutively active manner. The variant knocked-in mice tended to spontaneously develop dermatitis similar to human atopic dermatitis. We propose that an exaggerated STAT6 response is a novel mechanism of allergic symptoms, which is a good therapeutic target. This mechanism has been shown in subsequent papers and is being established as a new entity of allergic diseases. We will also discuss recent findings surrounding STAT6.</p>

収録刊行物

詳細情報 詳細情報について

問題の指摘

ページトップへ